Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up

References

• Brinton L. Long-term effects of ovulation-stimulating drugs on cancer risk. Reprod Biomed Online 2007;15:38–44.
   PubMed Web of Science ®Google Scholar
• Brinton LA, Moghissi KS, Scoccia B, Westhoff CL, Lamb EJ. Ovulation induction and cancer risk. Fertil Steril 2005;83:261–74; quiz 525.
   PubMed Web of Science ®Google Scholar
• Cetin I, Cozzi V, Antonazzo P. Infertility as a cancer risk factor - a review. Placenta 2008;29 Suppl B:169–177.
   PubMedGoogle Scholar
• Klip H, Burger CW, Kenemans P, van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control 2000;11:319–344.
   PubMedGoogle Scholar
• Cohen J, Forman R, Harlap S, Johannisson E, Lunenfeld B, de Mouzon J, Pepperell R, et al. IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents. Hum Reprod 1993;8:996–999.
   PubMed Web of Science ®Google Scholar
• Meirow D, Schenker JG. The link between female infertility and cancer: epidemiology and possible aetiologies. Hum Reprod Update 1996;2:63–75.
   PubMedGoogle Scholar
• Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, Serr D. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987;125:780–790.
   PubMed Web of Science ®Google Scholar
• Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J, Oelsner G, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998;147:1038–1042.
   PubMed Web of Science ®Google Scholar
• Fathalla MF. Incessant ovulation – a factor in ovarian neoplasia? Lancet 1971;2:163.
   PubMed Web of Science ®Google Scholar
• Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717–721.
   PubMedGoogle Scholar
• Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1212–1220.
   PubMed Web of Science ®Google Scholar
• Shu XO, Brinton LA, Gao YT, Yuan JM. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989;49:3670–3674.
   PubMed Web of Science ®Google Scholar
• Franceschi S, La Vecchia C, Negri E, Guarneri S, Montella M, Conti E, Parazzini F. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994;9:1673–1675.
   PubMed Web of Science ®Google Scholar
• Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996;65:13–18.
   PubMed Web of Science ®Google Scholar
• Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997;67:1005–1012.
   PubMed Web of Science ®Google Scholar
• Parazzini F, Negri E, La Vecchia C, Moroni S, Franceschi S, Crosignani PG. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod 1997;12:2159–2161.
   PubMed Web of Science ®Google Scholar
• Parazzini F, Pelucchi C, Negri E, Franceschi S, Talamini R, Montella M, La Vecchia C. Use of fertility drugs and risk of ovarian cancer. Hum Reprod 2001;16:1372–1375.
   PubMed Web of Science ®Google Scholar
• Ness RB, Cramer DW, Goodman MT, Kjaer SK, Mallin K, Mosgaard BJ, Purdie DM, et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 2002;155:217–224.
   PubMed Web of Science ®Google Scholar
• Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771–776.
   PubMed Web of Science ®Google Scholar
• Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995;346:995–1000.
   PubMed Web of Science ®Google Scholar
• Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in vitro fertilisation. Lancet 1999;354:1586–1590.
   PubMed Web of Science ®Google Scholar
• Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 1999;71:853–859.
   PubMed Web of Science ®Google Scholar
• Doyle P, Maconochie N, Beral V, Swerdlow AJ, Tan SL. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 2002;17:2209–2213.
   PubMed Web of Science ®Google Scholar
• Dor J, Lerner-Geva L, Rabinovici J, Chetrit A, Levran D, Lunenfeld B, Mashiach S, Modan B. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002;77:324–327.
   PubMed Web of Science ®Google Scholar
• Lerner-Geva L, Geva E, Lessing JB, Chetrit A, Modan B, Amit A. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer 2003;13:23–27.
   PubMed Web of Science ®Google Scholar
• Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 2004;103:1194–1203.
   PubMed Web of Science ®Google Scholar
• Tworoger SS, Fairfield KM, Colditz GA, Rosner BA, Hankinson SE. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol 2007;166:894–901.
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Friedlander Y, Yanetz R, Kleinhaus K, Perrin MC, Manor O, Harlap S, Paltiel O. Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 2009;169:365–375.
   PubMed Web of Science ®Google Scholar
• Sanner K, Conner P, Bergfeldt K, Dickman P, Sundfeldt K, Bergh T, Hagenfeldt K, et al. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden. Fertil Steril 2009;91:1152–1158.
   PubMed Web of Science ®Google Scholar
• Jensen A, Sharif H, Frederiksen K, Kjaer SK. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. BMJ 2009;338:b249.
   PubMedGoogle Scholar
• Shoham Z. Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: where are we today? Fertil Steril 1994;62:433–448.
   PubMed Web of Science ®Google Scholar
• Kashyap S, Moher D, Fung MF, Rosenwaks Z. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis. Obstet Gynecol 2004;103:785–794.
   PubMed Web of Science ®Google Scholar
• van Leeuwen FE, Klip H, Mooij TM, van de Swaluw AM, Lambalk CB, Kortman M, Laven JS, et al. Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod 2011;26:3456–3465.
   PubMed Web of Science ®Google Scholar
• Menczer J, Lerner-Geva L, Sade-Bruchim RB, Friedman E. Lack of the predominant BRCA1 and BRCA2 mutations in Jewish ovarian carcinoma patients who previously underwent ovulation induction. Eur J Gynaecol Oncol 1999;20:371–372.
   PubMedGoogle Scholar
• Harris R, Whittemore AS, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1204–1211.
   PubMed Web of Science ®Google Scholar
• Hirsh-Yechezkel G, Chetrit A, Lubin F, Friedman E, Peretz T, Gershoni R, Rizel S, et al. Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel. Gynecol Oncol 2003;89:494–498.
   PubMedGoogle Scholar
• Harding M, Cowan S, Hole D, Cassidy L, Kitchener H, Davis J, Leake R. Estrogen and progesterone receptors in ovarian cancer. Cancer 1990;65:486–491.
   PubMed Web of Science ®Google Scholar
• Gotlieb WH, Chetrit A, Menczer J, Hirsh-Yechezkel G, Lubin F, Friedman E, Modan B, Ben-Baruch G; National Israel Ovarian Cancer Study Group. Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer. Gynecol Oncol 2005;97:780–783.
   PubMed Web of Science ®Google Scholar
• Lee E, Ma H, McKean-Cowdin R, Van Den Berg D, Bernstein L, Henderson BE, Ursin G. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Cancer Epidemiol Biomarkers Prev 2008;17:3170–3178.
   PubMed Web of Science ®Google Scholar
• Borini A, Rebellato E. Focus on breast and ovarian cancer. Placenta 2008;29 Suppl B:184–190.
   PubMedGoogle Scholar
• Gammon MD, Thompson WD. Infertility and breast cancer: a population-based case-control study. Am J Epidemiol 1990;132:708–716.
   PubMed Web of Science ®Google Scholar
• Braga C, Negri E, La Vecchia C, Parazzini F, Dal Maso L, Franceschi S. Fertility treatment and risk of breast cancer. Hum Reprod 1996;11:300–303.
   PubMed Web of Science ®Google Scholar
• Ricci E, Parazzini F, Negri E, Marsico S, La Vecchia C. Fertility drugs and the risk of breast cancer. Hum Reprod 1999;14:1653–1655.
   PubMed Web of Science ®Google Scholar
• Burkman RT, Tang MT, Malone KE, Marchbanks PA, McDonald JA, Folger SG, Norman SA, et al. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women’s Contraceptive and Reproductive Experiences Study. Fertil Steril 2003;79:844–851.
   PubMed Web of Science ®Google Scholar
• Cowan LD, Gordis L, Tonascia JA, Jones GS. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 1981;114:209–217.
   PubMed Web of Science ®Google Scholar
• Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403–407.
   PubMed Web of Science ®Google Scholar
• Brinton LA, Melton LJ 3rd, Malkasian GD Jr, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989;129:712–722.
   PubMed Web of Science ®Google Scholar
• Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of breast cancer in a cohort of infertile women. Gynecol Oncol 1996;60:3–7.
   PubMed Web of Science ®Google Scholar
• Gauthier E, Paoletti X, Clavel-Chapelon F; E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 2004;19:2216–2221.
   PubMed Web of Science ®Google Scholar
• Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Althuis MD, Mabie JE, Lamb EJ. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 2004;19:2005–2013.
   PubMed Web of Science ®Google Scholar
• Terry KL, Willett WC, Rich-Edwards JW, Michels KB. A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Arch Intern Med 2006;166:2484–2489.
   PubMedGoogle Scholar
• Lerner-Geva L, Keinan-Boker L, Blumstein T, Boyko V, Olmar L, Mashiach S, Rabinovici J, et al. Infertility, ovulation induction treatments and the incidence of breast cancer – a historical prospective cohort of Israeli women. Breast Cancer Res Treat 2006;100:201–212.
   PubMed Web of Science ®Google Scholar
• Jensen A, Sharif H, Svare EI, Frederiksen K, Kjaer SK. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiol Biomarkers Prev 2007;16:1400–1407.
   PubMed Web of Science ®Google Scholar
• Orgéas CC, Sanner K, Hall P, Conner P, Holte J, Nilsson SJ, Sundfeldt K, et al. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study. Am J Obstet Gynecol 2009;200:72.e1–72.e7.
   Google Scholar
• Brzezinski A, Peretz T, Mor-Yosef S, Schenker JG. Ovarian stimulation and breast cancer: is there a link? Gynecol Oncol 1994;52:292–295.
   PubMed Web of Science ®Google Scholar
• Pappo I, Lerner-Geva L, Halevy A, Olmer L, Friedler S, Raziel A, Schachter M, Ron-El R. The possible association between IVF and breast cancer incidence. Ann Surg Oncol 2008;15:1048–1055.
   PubMed Web of Science ®Google Scholar
• Kristiansson P, Björ O, Wramsby H. Tumour incidence in Swedish women who gave birth following IVF treatment. Hum Reprod 2007;22:421–426.
   PubMed Web of Science ®Google Scholar
• Zreik TG, Mazloom A, Chen Y, Vannucci M, Pinnix CC, Fulton S, Hadziahmetovic M, et al. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res Treat 2010;124:13–26.
   PubMed Web of Science ®Google Scholar
• Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH, Brinton LA. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 2005;161:607–615.
   PubMed Web of Science ®Google Scholar
• Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T, Atiomo W, Menon PA, et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006;21:924–929.
   PubMed Web of Science ®Google Scholar
• Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 2000;3:101–105.
   PubMedGoogle Scholar
• Papaioannou S, Tzafettas J. Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer. Best Pract Res Clin Obstet Gynaecol 2010;24:19–27.
   PubMedGoogle Scholar
• Benshushan A, Paltiel O, Brzezinski A, Tanos V, Barchana M, Shoshani O, Gordon L, et al. Ovulation induction and risk of endometrial cancer: a pilot study. Eur J Obstet Gynecol Reprod Biol 2001;98:53–57.
   PubMedGoogle Scholar
• Brinton LA, Moghissi KS, Scoccia B, et al. Ovulation induction and cancer risk. Fertil Steril 2005;83:261–274.
   PubMed Web of Science ®Google Scholar